wouldn't take the risk to sell now .. what if ESG goes into trading halt and some big news comes out..ouch that would hurt if you just sold.go ESG
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%